Epidemiology of Hepatitis C Virus in HIV Patients from West Mexico: Implications for Controlling and Preventing Viral Hepatitis
Pathogens · 2024
DOI: 10.3390/pathogens13050360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Alexis Jose-Abrego und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine in Hepatology, Civil Hospital of Guadalajara, "Fray Antonio Alcalde", Guadalajara 44280, Jalisco, Mexico. Hauptthemen laut MEDLINE: HIV Infections, Hepacivirus, Hepatitis C, Liver Cirrhosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías, University of Guadalajara, Consejo Nacional de Humanidades, Ciencias, y Tecnologías (CONAHCYT).
Abstract (Originalsprache)
The complex epidemiology of hepatitis C virus (HCV) infection among human immunodeficiency virus (HIV) patients in West Mexico remains poorly understood. Thus, this study aimed to investigate the HCV prevalence, HCV-associated risk factors, and HCV genotypes/subtypes and assess their impacts on liver fibrosis in 294 HIV patients (median age: 38 years; 88.1% male). HCV RNA was extracted and amplified by PCR. Hepatic fibrosis was assessed using three noninvasive methods: transient elastography (TE), the aspartate aminotransferase (AST)-to-platelets ratio index score (APRI), and the fibrosis-4 score (FIB4). Patients with liver stiffness of ≥9.3 Kpa were considered to have advanced liver fibrosis. HCV genotypes/subtypes were determined by line probe assay (LiPA) or Sanger sequencing. The prevalence of HIV/HCV infection was 36.4% and was associated with injection drug use (odds ratio (OR) = 13.2; 95% confidence interval (CI) = 5.9–33.6; p < 0.001), imprisonment (OR = 3.0; 95% CI = 1.7–5.4; p < 0.001), the onset of sexual life (OR = 2.6; 95% CI = 1.5–4.5; p < 0.001), blood transfusion (OR = 2.5; 95% CI = 1.5–4.2; p = 0.001), tattooing (OR = 2.4; 95% CI = 1.4–3.9; p = 0.001), being a sex worker (OR = 2.3; 95% CI = 1.0–5.4; p = 0.046), and surgery (OR = 1.7; 95% CI = 1.0–2.7; p = 0.042). The HCV subtype distribution was 68.2% for 1a, 15.2% for 3a, 10.6% for 1b, 3.0% for 2b, 1.5% for 2a, and 1.5% for 4a. The advanced liver fibrosis prevalence was highest in patients with HIV/HCV co-infection (47.7%), especially in those with HCV subtype 1a. CD4+ counts, albumin, direct bilirubin, and indirect bilirubin were associated with liver fibrosis. In conclusion, HCV infection had a significant impact on the liver health of Mexican HIV patients, highlighting the need for targeted preventive strategies in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine in Hepatology, Civil Hospital of Guadalajara, "Fray Antonio Alcalde", Guadalajara 44280, Jalisco, Mexico.
- Health Sciences Center, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico.
ORCID-Profile: Saul Laguna-Meraz
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- University of Guadalajara
- Consejo Nacional de Humanidades, Ciencias, y Tecnologías (CONAHCYT)
- Programa de Fortalecimiento de Institutos, Centros, y Laboratorios de Investigación 2021, Universidad de Guadalajara
Zitieren
APA
Jose-Abrego, A., Trujillo-Trujillo, M. E., Laguna-Meraz, S., Roman, S., & Panduro, A. (2024). Epidemiology of Hepatitis C Virus in HIV Patients from West Mexico: Implications for Controlling and Preventing Viral Hepatitis. Pathogens. https://doi.org/10.3390/pathogens13050360
Vancouver
Jose-Abrego A, Trujillo-Trujillo ME, Laguna-Meraz S, Roman S, Panduro A. Epidemiology of Hepatitis C Virus in HIV Patients from West Mexico: Implications for Controlling and Preventing Viral Hepatitis. Pathogens. 2024. doi:10.3390/pathogens13050360
BibTeX
@article{JoseAbrego2024,
author = {Jose-Abrego, Alexis and Trujillo-Trujillo, Maria E and Laguna-Meraz, Saul and Roman, Sonia and Panduro, Arturo},
title = {Epidemiology of Hepatitis C Virus in HIV Patients from West Mexico: Implications for Controlling and Preventing Viral Hepatitis},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13050360}
}
EUVIMED